Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (258)
NICE advice (26)
Quality standard (13)
Guidance programme
Guidance programme
Cancer service guidelines (5)
Clinical guidelines (17)
Diagnostics guidance (11)
Health technology evaluations (1)
Interventional procedures guidance (44)
Medical technologies guidance (3)
NICE guidelines (23)
Public health guidelines (1)
Social care guidelines (2)
Technology appraisal guidance (176)
Apply filters
Showing 31 to 40 of 258
Sort by
Date
Title
Apply sorting
cancer
Remove cancer filter
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung
cancer
TA898
14 June 2023
14 June 2023
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal
cancer
IPG763
6 June 2023
6 June 2023
Transperineal biopsy for diagnosing prostate
cancer
DG54
1 June 2023
1 June 2023
MRI fusion biopsy systems for diagnosing prostate
cancer
DG53
24 May 2023
24 May 2023
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast
cancer
after chemotherapy
TA886
10 May 2023
10 May 2023
Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate
cancer
TA887
10 May 2023
10 May 2023
Capmatinib for treating advanced non-small-cell lung
cancer
with MET exon 14 skipping (terminated appraisal)
TA884
3 May 2023
3 May 2023
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction
cancer
after anti-HER2 treatment (terminated appraisal)
TA879
6 April 2023
6 April 2023
Focal therapy using high-intensity focused ultrasound for localised prostate
cancer
IPG756
5 April 2023
5 April 2023
Maximal cytoreductive surgery for advanced ovarian
cancer
IPG757
5 April 2023
5 April 2023
Previous page
1
2
3
Current page
4
5
6
…
26
Page
4
of
26
Next page
Results per page
10
25
50
All
Back to top